Conference program

The final conference program will include podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers are international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe. 

Program schedule overview

Wednesday, July 18 – afternoon registration hours (Attendees may also check in at the registration desk the following morning.)
Thursday, July 19 – full day of programming
Friday, July 20 – full day of programming
Saturday, July 21 – morning programming


Global Ocular Oncology

Brenda Gallie, MD, FRCSC, SickKids Hospital & University of Toronto, Canada
Retinoblastoma can be a Zero Death Cancer

Rubens Belfort Neto, MD, PhD, Federal University of São Paulo, Brazil
Brazilian Model for Addressing Gaps in Access to Ocular Oncology

Junyang Zhao, MD, MsD, Beijing Childrens Hospital & Capital Medical University, China
Coordinating Care for Ocular Tumors Across a Large Population Base: Management of retinoblastoma in China

Basic Science Research

Steffen Heegaard, MD, PhD, University of Copenhagen, Denmark
Basic Mechanisms of Conjunctival and Orbital Lymphoma

Sarah Coupland, MBBS, PhD, Royal Liverpool Hospital, United Kingdom
Basic Mechanisms of Intraocular Lymphoma 

Bruce Ksander, Schepens Eye Institute, Harvard University, United States
Pathogenesis of Ocular (conjunctival and uveal) Melanoma

Martine Jager, MD, PhD, Leiden University, The Netherlands
Immunology of Ocular (conjunctival and uveal) Melanoma                 

Hans Grossniklaus, MD, Emory University, United States
Metastatic Mechanisms of Uveal Melanoma – the Zimmerman Effect

Clinical Research

Dan Gombos, MD, MD Anderson Cancer Center, United States
Treatment of Primary and Metastatic Uveal Melanoma

Swathi Kaliki, MD, LV Prasad Eye Institute, India
Latest in the Management of Ocular Surface Squamous Neoplasia

Jasmine Francis, Memorial Sloan Kettering Cancer Center, United States
Current Treatment of Retinoblastoma: Ophthalmic artery chemotherapy and intravitreal chemotherapy

Jacob Pe’er, Hadassah - Hebrew University Medical Center, Israel
Current Management of Primary Vitreo-Retinal Lymphoma

Plus Panel discussions involving the invited speakers on management of ocular surface tumors and intraocular tumors

And Looking to the Future

Arun Singh, MD, Cleveland Clinic, United States
Complications of Current Oncologic Treatments

Jose Pulido, MD, Mayo Clinic, United States
The Hamartia of Check-Point Inhibitors and the Emergence of Viroimmunotherapy for Uveal Melanomas

Laurence Desjardins, Institut Curie, France
The Future in Management of Ocular Tumors: Multicenter initiatives, novel diagnostics and therapies